{{Rsnum
|rsid=8049607
|Chromosome=16
|position=11597897
|Orientation=plus
|GMAF=0.4977
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 23.0 | 54.9 | 22.1
| HCB | 33.6 | 46.0 | 20.4
| JPT | 22.1 | 44.2 | 33.6
| YRI | 33.3 | 46.3 | 20.4
| ASW | 26.3 | 49.1 | 24.6
| CHB | 33.6 | 46.0 | 20.4
| CHD | 43.1 | 44.0 | 12.8
| GIH | 20.8 | 45.5 | 33.7
| LWK | 32.7 | 45.5 | 21.8
| MEX | 13.8 | 39.7 | 46.6
| MKK | 26.9 | 51.3 | 21.8
| TSI | 17.6 | 55.9 | 26.5
| HapMapRevision=28
}}[http://blog.23andme.com/2009/03/23/snpwatch-researchers-identify-genetic-variants-linked-to-heart-rhythm-and-possibly-sudden-cardiac-death/ 23andMe blog] Influences [[QT interval]]

{{PMID Auto GWAS
|PMID=19305408
|Trait=QT interval
|Title=Common variants at ten loci influence QT interval duation in the QTGEN Study
|RiskAllele=T
|Pval=5E-15
|OA=1
}}
{{PMID Auto GWAS
|PMID=19305409
|Trait=QT interval
|Title=Common variants at ten loci modulate the QT interval duration in the QTSCD Study
|RiskAllele=T
|Pval=6E-15
|OR=1.25
|ORtxt=[0.81-1.69] ms increase
|OA=1
}}

{{PharmGKB
|RSID=rs8049607
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19305408; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Common variants at ten loci influence QT interval duation in the QTGEN Study. (Initial Sample Size: 13,685 individuals; Replication Sample Size: 15,854 individuals); (Region: 16p13.13; Reported Gene(s): LITAF,CLEC16A, SNN, ZC3H7A, TNFRSF17; Risk Allele: rs8049607-T); (p-value= 0.000000000000005).This variant is associated with QT interval.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164739888
}}

{{PharmGKB
|RSID=rs8049607
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19305409; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Common variants at ten loci modulate the QT interval duration in the QTSCD Study. (Initial Sample Size: 15,842 individuals; Replication Sample Size: up to 13,602 individuals); (Region: 16p13.13; Reported Gene(s): LITAF; Risk Allele: rs8049607-T); (p-value= 0.000000000000006).This variant is associated with QT interval.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164739905
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs8049607
|overall_frequency_n=68
|overall_frequency_d=128
|overall_frequency=0.53125
|n_genomes=41
|n_genomes_annotated=0
|n_haplomes=55
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{PMID Auto GWAS
  |PMID=23166209
  |Trait=QT interval
  |Title=Impact of Ancestry and Common Genetic Variants on QT Interval in African Americans.
  |RiskAllele=C
  |Pval=7E-7
  |OR=1.63
  |ORtxt=[0.98-2.28] unit decrease
  |OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}